Market Insights Health OTC Pharmaceuticals

Digestives & Intestinal Remedies - Zambia

Zambia

In Zambia, the Digestives & Intestinal Remedies market market generates a revenue of US$4.42m in 2024.
It is projected to experience an annual growth rate of 6.37% (CAGR 2024-2029).
When compared globally, in China leads the market with a revenue of US$4,408.00m in 2024.
In terms of per person figures, the revenue generated amounts to US$0.21 in 2024.
In Zambia, there is a growing demand for digestive and intestinal remedies in the OTC Pharmaceuticals market, driven by increasing awareness of digestive health and changing dietary habits.

Key regions: Canada, United States, Australia, Brazil, Japan

Market

Region

Region comparison

Currency

Analyst Opinion

The Digestives & Intestinal Remedies market in Zambia has been experiencing significant growth in recent years.

Customer preferences: Zambian consumers are increasingly becoming health-conscious and are seeking products that can help improve their digestive health. This has led to a growing demand for Digestives & Intestinal Remedies in the market. Consumers are looking for products that can provide relief from common digestive issues such as indigestion, bloating, and constipation. They are also interested in natural and herbal remedies that are perceived to be safer and have fewer side effects.

Trends in the market: One of the key trends in the Digestives & Intestinal Remedies market in Zambia is the rising popularity of probiotic products. Probiotics are live bacteria and yeasts that are beneficial for digestive health. They are believed to help restore the natural balance of bacteria in the gut and improve digestion. Probiotic supplements and yogurts have gained significant traction among Zambian consumers who are looking to maintain a healthy digestive system.Another trend in the market is the increasing availability of over-the-counter (OTC) Digestives & Intestinal Remedies. Previously, consumers had limited access to such products and had to rely on traditional remedies or prescription medications. However, with the expansion of the retail sector and the introduction of new products, consumers now have a wider range of options to choose from. This has made it more convenient for consumers to purchase Digestives & Intestinal Remedies and has contributed to the market growth.

Local special circumstances: Zambia has a high prevalence of gastrointestinal diseases and disorders, which has further fueled the demand for Digestives & Intestinal Remedies. Factors such as poor sanitation, contaminated water sources, and inadequate healthcare infrastructure contribute to the prevalence of digestive health issues in the country. As a result, there is a greater need for products that can provide relief and improve the overall digestive health of the population.

Underlying macroeconomic factors: Zambia has experienced steady economic growth in recent years, which has contributed to the increased purchasing power of consumers. This has allowed more individuals to afford Digestives & Intestinal Remedies and invest in their health. Additionally, the government's focus on improving healthcare services and infrastructure has also played a role in driving the market growth. As healthcare facilities become more accessible, consumers are becoming more aware of the importance of digestive health and are seeking appropriate remedies.In conclusion, the Digestives & Intestinal Remedies market in Zambia is witnessing significant growth due to the increasing health-consciousness among consumers, the popularity of probiotic products, the availability of OTC remedies, the prevalence of gastrointestinal diseases, and the country's improving economic conditions. As the market continues to evolve, it is expected that there will be further innovations and advancements in Digestives & Intestinal Remedies to meet the growing demand in Zambia.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.